This activation subsequently enhances the phosphorylation of YAP/TAZ by LATS1/2, leading to the cytoplasmic retention of these pro-proliferative transcriptional co-activators and ultimately inhibiting aberrant tumor cell growth (Hong et al., 2020; Wu et al., 2024). Here, LATS1 is linked to neoplasm.